Short Interest in Exponent, Inc. (NASDAQ:EXPO) Decreases By 11.1%

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 1,520,000 shares, a decline of 11.1% from the September 15th total of 1,710,000 shares. Based on an average daily volume of 196,200 shares, the days-to-cover ratio is presently 7.7 days. Approximately 3.0% of the company's stock are short sold.

Insider Buying and Selling

In related news, VP John Pye sold 3,956 shares of the business's stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total transaction of $415,380.00. Following the transaction, the vice president now directly owns 28,422 shares in the company, valued at approximately $2,984,310. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by corporate insiders.

Institutional Trading of Exponent

Hedge funds and other institutional investors have recently modified their holdings of the business. Quarry LP bought a new stake in shares of Exponent in the second quarter valued at approximately $25,000. GAMMA Investing LLC grew its stake in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider's stock valued at $36,000 after acquiring an additional 153 shares in the last quarter. Benjamin F. Edwards & Company Inc. grew its stake in Exponent by 866.0% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider's stock valued at $42,000 after acquiring an additional 459 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its stake in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider's stock valued at $49,000 after acquiring an additional 323 shares in the last quarter. Finally, USA Financial Formulas purchased a new position in Exponent during the third quarter valued at approximately $60,000. Institutional investors own 92.37% of the company's stock.

Analysts Set New Price Targets

Separately, Truist Financial reaffirmed a "buy" rating and issued a $120.00 price objective (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Stock Performance

EXPO stock traded up $0.73 during mid-day trading on Tuesday, hitting $113.79. The company had a trading volume of 142,933 shares, compared to its average volume of 247,841. The stock's fifty day moving average price is $107.99 and its two-hundred day moving average price is $98.48. Exponent has a 12 month low of $64.61 and a 12 month high of $115.61. The firm has a market cap of $5.77 billion, a PE ratio of 57.10 and a beta of 0.66.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The company had revenue of $132.43 million for the quarter, compared to analyst estimates of $130.83 million. During the same quarter in the previous year, the firm posted $0.50 earnings per share. The company's quarterly revenue was up 2.1% compared to the same quarter last year. Equities analysts anticipate that Exponent will post 2.04 earnings per share for the current year.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were given a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 0.98%. The ex-dividend date was Friday, September 6th. Exponent's dividend payout ratio (DPR) is currently 56.57%.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.